The formation of membrane microparticles through vesiculation of the platelet plasma membrane is known t o provide catalytic surface for several enzyme complexes of the coagulation system, and t o underlie the procoagulant responses elicited with platelet activation. This induced shedding of vesicles from the plasma membrane is most prominent when platelets are activated by the terminal complement proteins, C5b-9, by a Ca'+ ionophore, or by the combination of thrombin plus collagen. Although shown to require elevated [Ca''], the cellular events that initiate plasma membrane evagination and fusion t o form the shed vesicles remain unresolved. To gain additional insight into the cellular events that regulate membrane microparticle formation, we have examined how this process is influenced by the activity of cellular protein kinases. Cytoplasmic [Ca"] of gel-filtered platelets was increased by membrane assembly of the terminal complement proteins C5b-9 in the presence of selective inhibitors of protein kinase or phosphatase reactions, and
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CTIVATION OF platelets by a variety of agonists
A induces platelet shape change, secretion of a-and dense-granule storage pools, activation of surface receptors for adhesive proteins, and induction of procoagulant activity. Expression of the procoagulant properties of activated platelets has been shown to be related to the exposure of binding sites for assembly of the tenase and prothrombinase enzyme complexes on small membrane vesicles ("microparticles") that are shed from the platelet surface upon activation.'-6 The mechanism by which this vesiculation of the plasma membrane of activated platelets is initiated and regulated remains unresolved. Cumulative data suggest that the capacity of an agonist to induce formation of these membrane microparticles is directly related to its ability to raise cytosolic [Ca2+].4,5 Because proteolytic degradation of membrane-associated cytoskeletal proteins by cytosolic calpains is often observed concomitant with membrane vesiculation, it has been suggested that this action of Ca"-plus-calpain initiates vesiculation by dissociating plasma membrane proteins from the submembrane cytoskeleton. ' The observation that platelet microparticle formation and the expression of platelet prothrombinase activity can proceed unimpeded when intracellular resulting microparticle formation was quantitated by fluorescence-gated flow cytometry. Pie-equilibration of the phosphatase inhibitor vanadate into the platelet cytosol increased microparticle formation by as much as 40%. suggesting that vesiculation of the platelet plasma membrane is influenced by the state of phosphorylation of a cellular constituent. By contrast to the stimulatory effects of vanadate, microparticle formation was partially inhibited in platelets treated with the protein kinase inhibitor sphingosine, the myosin light chain kinase inhibitor ML-7, the calmodulin-antagonist W-7, and under conditions of elevated cytosolic concentration of cyclic adenosine monophosphate. These results indicate that complement-induced platelet microparticle formation is influenced by one or more protein kinase(s) as well as by calmodulin, and suggest a role for the platelet myosin light chain kinase or another Ca2+-pluscalmodulin-regulated membrane component. calpains are completely inhibited suggests alternative mechanisms by which Caz+ triggers this response. 538 We have previously shown that complement proteins C5b-9 differ from other physiologic agonists by their capacity to increase intracellular [Ca'+] and to activate cellular protein kinases through direct effects on the plasma membrane, bypassing the normal receptor-coupled pathways that require phospholipase C-mediated hydrolysis of inositol phospholipids to increase cytosolic [Ca"].' In addition to providing catalytic surface for the prothrombinase and tenase reactions, this vesiculation after C5b-9 assembly serves as a mechanism to remove these pore-forming proteins from the platelet surface, circumventing the cytolytic activity of the C5b-9 complex. Therefore, we have used these complement proteins to examine the role of phosphorylation events in the Cazf-requiring process of plasma membrane vesiculation. Our results suggest that in addition to a dependence on Caz+, the complement-induced shedding of vesicles from the platelet plasma membrane involves participation of one or more protein kinase(s), and is regulated by calmodulin. Gel-filtered human platelets were prepared and collected into buffer 1 at 1 to 2 X IO9/mL as described previously? Human complement proteins C5h6, C7, C8, and C9 were purified and analyzed for functional activity according to methods previously described.' To assemble membrane-bound C5b67 complexes, gel-filtered platelets (lO'/mL) were incubated for 3 minutes at 37°C with C5b6 (10 pg/108 platelets) and C7 (2.5 pg/ 10' cells). To assemble membrane-bound C5b-9 complexes, C5b67 platelets were suspended to 10' platelets/mL in buffer 2 containing0.l mmol/LEGTA. Then C8 (4 pg/108cells) and C9 (10 kg/108 cells) were added, and the cells incubated at 37°C without stirring for 2 minutes in the presence or absence of inhibitors of kinase or phosphatase as described in the figure legends. As previously described, assembly of the C5b-9 complex in 0.1 mmol/L EGTA results in the permeabilization of the platelet plasma membrane while maintaining low cytosolic calcium, thereby preventing activation of protein kinases and granule secretion? Platelet activation was then initiated by addition of 1 mmol/L CaC1, and incubation continued for another 10 minutes. Activation was stopped by the addition of 2 mmol/L EGTA. In all experiments, comparison was made to identical matched-pair controls (platelets incubated in the absence of the C5b-9 proteins).
Kinase inhibitors and calmodulin antagonists. Sphingosine was dissolved in buffer 2. Staurosporin was delivered to platelets from a stock solution in dimethyl sulfoxide, with the solvent concentration never exceeding 0.6%. ML-7, W-5, and W-7 were maintained as stock solutions in water and diluted into buffer 2 shortly before use.
Platelets were labeled with "P, as described elsewhere.' C5b-9 assembly was then performed as described above and as detailed in the figure legends. In all cases, platelet activation was stopped 30 seconds after addition of 1 mmol/L CaC1, by dilution into hot sodium dodecyl sulfate (SDS) sample buffer as described.' Aliquots of 50 kL (1.3 x lo7 platelets) were loaded onto 12% SDS polyacrylamide gels. The gels were stained, dried, and autoradiographed using Kodak BB-5 Blue Brand x-ray film (Kodak, Rochester, NY).
Antibody S12 was labeled with FITC' and antibody AP1 was conjugated with N-hydroxysuccinimide biotin ester" as previously described.
C5b-9-treated or control platelets, 5 X lo6, were incubated in the dark in a total volume of 60 kL for 10 minutes at 23°C in the presence of biotin-AP1 (2 pg/mL) and FITC-S12 (30 kg/mL). Phycoerythrinstreptavidin was added (5 pL of a 1:10 dilution), and the cells were incubated an additional 10 minutes. Then 1-mL aliquots of buffer 2 were added and the samples analyzed by flow cytometry.
Samples were analyzed in a Becton Dickinson FACScan flow cytometer (Mountain View, CA) formatted for two-color analysis as described previously.'2 To discriminate between platelets and microparticles, gates for analysis were set as described.' ''
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RESULTS
Ca2'-induced vesiculation of the platelet plasma membrane is potentiated by vanadate. Assembly of the terminal complement proteins C5b-9 on the platelet plasma membrane results in an increase in cytosolic [Caz+] , which is accompanied by secretion of the contents of the storage granules and by shedding of plasma membrane-derived vesicles from the platelet s~r f a c e .~~~ In addition to removing the inserted C5b-9 proteins from the platelet surface, these membrane "microparticles" provide catalytic surface for assembly of the prothrombinase and tenase enzyme complexes, accounting for expression of the platelet's procoagulant properties.'-6 Although little is known about the mechanism by which C5b-9 assembly induces vesiculation of the platelet plasma membrane, the formation of these microparticles For personal use only. on October 30, 2017. by guest www.bloodjournal.org From has been shown to be regulated by intracellular Ca2+ and to be inhibited when the influx of Ca2+ is precluded.'Bs To gain additional insight into the obligate role of Ca2+ in this process of induced vesiculation of the platelet plasma membrane, we have investigated the contribution of Ca2+-regulated protein kinases to the formation of the platelet membrane vesicles. Gel-filtered platelets were exposed to complement proteins C5b-9 in the presence of 2 mmol/L ATP and increasing concentrations of the phosphatase inhibitor vanadate to elevate the state of phosphorylation of cytosolic proteins.'' In these experiments the CSb-9 complex was assembled in the presence of 0.1 mmol/L EGTA to permeabilize the plasma membrane to vanadate and ATP before influx of Ca", and platelet activation was subsequently initiated by the addition of 1 mmol/L CaC1, (Fig 1, closed symbols) . Under these conditions, the addition of vanadate was found to potentiate both C5b-9-induced secretion from a-granules (Fig 1, upper panel) and the formation of plasma membrane-derived microparticles (Fig 1, lower panel) by approximately 40%. These effects of vanadate saturated at [vanadate] > 100 p.mol/L. In the absence of added Ca2+, both microparticle formation and a-granule secretion were inhibited (open symbols). Furthermore, in contrast to results obtained at elevated [Ca'+], when C5b-9 platelets were maintained in 0.1 mmol/L EGTA, the addition of vanadate caused little increase in microparticle formation, although secretion was near maximally stimulated at 1 mmol/L vanadate. No secretion or microparticle formation was induced when these concentrations of vanadate were added to complement-free controls suspended in either 1 mmol/L CaCI, or 0.1 mmol/L EGTA (data not shown). Taken together, these data suggest that the CSb-9-induced vesiculation of the platelet plasma membrane is influenced by both Caz+ and by the extent of phosphorylation of an intracellular component.
As shown in Fig 2, both a-granule secretion and plasma membrane vesicle formation were inhibited by approximately 25% when C5b-9 platelets were exposed to dibutyryl CAMP before Ca2+ addition. Similar results were obtained with PGE,. These results suggest that
Inhibition by CAMP.
in addition to a dependence on CaZ+, the process of plasma membrane vesiculation is also sensitive to the level of cytoplasmic CAMP.
Contribution of protein kinases to membrane microparticle formation. The possible role of a phosphorylated membrane component in the Caz+-induced shedding of vesicles from the platelet plasma membrane led us to examine the contribution of cellular protein kinases to this process. As shown in Fig 3, sphingosine, a relatively nonspecific protein kinase inhibit~r,'~ had a marked inhibitory effect on the shedding of vesicles from C5b-9-treated platelets, which paralleled its inhibitory effect on a-granule secretion. By contrast, in platelets treated with the relatively selective C-kinase inhibitor, staurosporine, only a small inhibition of platelet microparticle formation was observed, despite a marked inhibition of a-granule secretion under these conditions (Fig 4) . As illustrated in Fig 5, the concentrations of staurosporine used in these experiments virtually abolished CSb-9-induced phosphorylation of the 40-Kd substrate of protein kinase C, as well as inhibited other phosphorylations, including that of myosin light chain (20 Kd; see below). Taken together with the results in Fig 2, these data suggest that whereas the activity of the platelet C-kinases is required for C5b-9-induced a-granule secretion, it is not required for vesiculation of the plasma membrane, and that another protein kinase(s) sensitive to the effects of both Ca2+ and cAMP participates in this event.
Because of the known regulation of the activity of myosin light chain kinase by both Ca2+ and CAMP, we next examined the effect of ML-7, a potent inhibitor of this enzyme.15 As shown in Fig 6 (lower  panel) , ML-7 at 50 p.mol/L reduced microparticle formation by approximately 35%. Under these conditions, a-granule secretion was inhibited by more than 80% (Fig 6, upper  panel) . As illustrated in Fig 7, at the concentrations of ML-7 required to observe inhibition of secretion and plasma membrane vesiculation (1.6 to 12.5 p.mol/L), a selective inhibition of the phosphorylation of myosin light chain (20 Kd) was observed, although higher concentrations of this compound partially reduced phosphorylation Role of myosin light chain kinase. 
DISCUSSION
Our results indicate that the vesiculation of plasma membrane that is observed when [Ca"] is increased in the platelet cytosol can be modulated by reagents that alter the state of phosphorylation of intracellular phosphoproteins, including inhibitors of protein kinase(s) and a direct calmodulin antagonist. Therefore, these data suggest that the shedding of vesicles from the platelet surface is metabolically regulated by the activity of one or more Ca2+-dependent protein kinases, in addition to any direct effect that Caz+ may have on the intrinsic stability of the plasma membrane. This conclusion is consistent with recent observations indicating that Ca2'-induced vesiculation of the platelet plasma membrane can proceed unimpeded under conditions where proteolytic degradation of the submembrane cytoskeleton by intracellular Ca2+-activated proteases is prevented, implying a dependence of vesicle formation on other Ca2+-regulated events that affect cytoskeletal organization and membrane s t r u c t~r e .~~~ -tn 7 0 1 of the 40-Kd C-kinase substrate, pleckstrin. While these results suggest that activation of myosin light chain kinase contributes to membrane microparticle formation, it should also be noted that at concentrations of staurosporine at which significant inhibition of both myosin light chain kinase and C-kinase(s) were observed, vesiculation of the plasma membrane was only slightly inhibited (Figs 4 and 5; see Discussion).
A calmodulin antagonkt inhibits vesiculation of the platelet plasma membrane. The effects of these protein kinase inhibitors, plus the obligate requirement for Caz+, suggested that a calmodulin-regulated kinase, possibly myosin light chain kinase, participates in platelet microparticle formation. Consistent with this interpretation, the calmodulin antagonist W-716 was found to inhibit microparticle formation (Fig 8) . Maximum inhibition by W-7 was observed at 50 pmol/L, a concentration at which the halide-free analogue W-5 (a weak calmodulin antagonist) had virtually no effect. Effect of staurosporine on C5b-%induced platelet protein phosphorylation. C5b67-complexes were assembled on l'P-labeled platelets as described in Materials and Methods and these cells suspended t o 4 x 10' cells/mL in buffer 2 containing 0.1 mmol/L EGTA plus 0 t o 10 pmol/L staurosporine. After additional incubation for 5 minutes at 37°C. C5b-9 assembly was completed as described in Materials and Methods. Thirty seconds after addition of 1 mmol/L CaCI,, aliquots were diluted into hot SDS sample buffer and subjected t o gel electrophoresis. Autoradiograph shows complement-treated (C5b-9) and untreated control (C) platelets.
As shown in Fig 1, platclct microparticle formation was potcntiatcd by vanadate, a potcnt inhibitor of tyrosine phosphatascs. Although scvcral protein kinasc inhibitors wcrc found t o cxcrt an inhibitory cffcct on the formation of thcsc vcsiclcs, thc rcportcd sclcctivity of the kinasc inhibitors uscd is for cnzymcs (cspccially C-kinases and myosin light chain kinasc) that mcdiatc scrinc/thrcnninc phosphorylation. However, it should bc notcd that in addition to bcing a potcnt inhibitor of tyrosine phosphatasc rcactions, vanadate has also bccn shown to incrcase formation of inositol-phosphates and thc phosphorylation of serine/ thrconinc phosphoproteins in pcrmcabilizcd platclcts," suggcsting that it potentiates the cffccts of a variety of cellular kinasc5 in addition to prcvcnting dcphosphorylation of phosphotyrosincs.
Although the incrcasc in microparticlc formation obscrvcd in vanadate-loadcd platclcts, and the inhibition of this proccss by certain protein kinasc inhibitors, implicatcs participation of one or morc protein kinases in platelet microparticlc formation, thcsc data lcavc unrcsolvcd which kinasc(s) arc directly involved. Sphingosinc (25 kmol/L) virtually abolished CSb-9-induced platelct sccrction and inhibircd vcsiclc formation by approximatcly SO% (Fig 3) . This compound, which was originally proposcd to be a specific inhibitor of protein k i n w C", has morc rcccntly bccn shown to inhibit othcr kinases as well, including the Ca"-activated myosin light chain kinasc and othcr calmodulin-dcpcndcnt cnzymcs." The rcquircmcnt for Ca" and thc inhibitory cffccts of both thc calmodulin antagonist, W-7, and thc myosin light chain kinase inhibitor, ML-7. arc cach consistcnt with thc participation of myosin light chain kinasc in the shape changes leading to evagination and fusion of plasma mcmbranc as required for vcsiculation of microparticlcs from thc platclct surface. Furthcrmorc, this cnzymc has been implicated in thc ccntralization of platclct storage granulcs during sccrction, a proccss that also rcquircs reorganization of thc platclct cytoskclcton." In addition to thc inhibitory cffccts of W-7 and ML-7, CAMP was also found to rcducc thc extent of microparticle formation (Fig 2, right panel) . Bccausc a CAMP-dependent completely abolish the vesiculation response induced by the C5b-9 proteins, even when added at apparently "saturating" concentrations (eg, see Figs 6 and 7). One possibility is that under the conditions of our cxpcriments, intracellular concentrations of these compounds required for complete cnzyme inhibition wcrc not achieved. Alternatively, these data may indicate that a kinasc reaction facilitates but is not obligatorily coupled to the Ca"-dependent step that is required for microparticle formation. Although we cannot cxcludc thc possibility that the membrane-inserted CSb-9 proteins directly induce vesiculation of the plasma membrane, irrespective of the metabolic changes that are initiated by influx of Ca" across the complement pore, it should be noted that: (1) in CSb-9-trcated platelets, microparticle formation shows strict dependence on [Ca'+], even though membrane insertion of these proteins does not,' and (2) in platelets obtained from the patient with Scott Syndrome, vcsiculation of the plasma membrane in re- , kinase is known to downrcgulate thc Ca'+/calmodulindependcnt activation of myosin light chain kinase,"' it is possible that the inhibitory cffcct of CAMP on plasma membrane vesiculation is exerted dircctly through thc phosphorylation of this cnzymc. Alternatively, the observed inhibition of vesiculation may be rclatcd to decreased cytosolic [Ca'+], arising secondarily to elevated CAMP." Despite this cumulativc evidence implicating the Ca"-pluscalmodulin-activated myosin light chain kinase in platelet microparticle formation, it should bc noted that the sclcctivc C-kinase inhibitor staurosporine was also observed to substantially inhibit phosphorylation of myosin light chain under the conditions of our cxpcrimcnts (Fig 4) , although it caused only modest inhibition of microparticlc formation (Fig 5) . Therefore, it is possiblc that the inhibition of protein phosphorylation that wc observc for these various enzyme inhibitors is neither temporally nor functionally related to their effects on microparticle formation. In this context, it is important to emphasize that although phosphorylation was mcasurcd 30 seconds aftcr addition of Ca" (the peak of phosphorylation in CSb-9 platelets; see Figs 9 and 10 of ref 9), microparticle formation, which procceds more slowly, was mcasurcd 10 minutes later (see Materials and Methods).
None of the inhibitors used in this study wcrc found to 
